Latest / DoctorX.AI / 【EN】Why Apple’s 'Medical License' Outweighs iPhone Sales for Long-Term Investors
Transcript
- 0:00SPEAKER_00: Welcome back to The Deep Dive.
- 0:01SPEAKER_00: Today,
- 0:02SPEAKER_00: we are looking at a company that everyone talks about,
- 0:05SPEAKER_00: yet so often gets criticized for being behind the curve,
- 0:10SPEAKER_00: Apple.
- 0:10SPEAKER_00: But we're not focusing on the latest iPhone sales or gadget drama.
- 0:14We're going deep into their most sober and revealing documents,
- 0:19their 10K financial filings.
- 0:21SPEAKER_00: And we're looking at a whole decade from 2016 right through 2025.
- 0:26SPEAKER_01: That's right.
- 0:27SPEAKER_01: And the conventional wisdom,
- 0:28SPEAKER_01: this idea that Apple is somehow lagging in the big AI race,
- 0:31SPEAKER_01: especially compared to rivals like Google,
- 0:34SPEAKER_01: that narrative,
- 0:35SPEAKER_01: we're arguing,
- 0:35SPEAKER_01: is just completely misleading.
- 0:37So our mission for you today is to really dissect the evidence
- 0:40that's buried in
- 0:40these filings and see if the financials actually support a much
- 0:43more aggressive
- 0:44SPEAKER_01: thesis that Apple has been executing a silent,
- 0:48SPEAKER_01: very disciplined maneuver,
- 0:49SPEAKER_01: something we're calling a dimensional reduction attack,
- 0:52SPEAKER_01: specifically in the medical space.
- 0:53SPEAKER_00: A dimensional reduction attack.
- 0:54SPEAKER_00: That sounds pretty intense.
- 0:56SPEAKER_00: What does that actually mean for our listeners?
- 0:59It means they're fundamentally changing their products from
- 1:02being a consumer
- 1:04SPEAKER_01: luxury,
- 1:04SPEAKER_01: a device you want,
- 1:06SPEAKER_01: to a critical life-embedded service,
- 1:09SPEAKER_01: a device you actually need.
- 1:11They are essentially shrinking the whole high-cost medical
- 1:15device market and
- 1:17SPEAKER_01: collapsing it down into something they already control,
- 1:20SPEAKER_01: a simple software update.
- 1:21SPEAKER_00: Okay, so let's unpack that because it starts with the money.
- 1:24SPEAKER_00: If they were supposedly lagging,
- 1:26SPEAKER_00: why were they pouring so much cash into research and development?
- 1:29SPEAKER_01: That is the core question.
- 1:31And the 10K is where we find the answer because it strips away
- 1:34all the marketing hype.
- 1:35SPEAKER_01: It's the unfiltered corporate strategy.
- 1:37SPEAKER_00: So what's the trajectory here?
- 1:38SPEAKER_00: What do the numbers say?
- 1:39SPEAKER_01: Well, back in 2016, Apple's R&D spend was already huge.
- 1:43SPEAKER_01: It was about $10 billion.
- 1:45SPEAKER_01: $10 billion.
- 1:45SPEAKER_01: That's a staggering number, but just watch how it grows.
- 1:49Three years later,
- 1:49by 2019,
- 1:50that investment had already jumped to over $16 billion.
- 1:53SPEAKER_01: Wow.
- 1:54And by 2025,
- 1:55according to the filings,
- 1:56that annual R&D spend is getting close to $32 billion.
- 2:01SPEAKER_00: That is explosive growth.
- 2:03SPEAKER_00: It's nearly doubling in just six years.
- 2:05SPEAKER_00: But OK, let me push back on that for a second.
- 2:07SPEAKER_01: Yeah, please.
- 2:08SPEAKER_00: Couldn't that massive spend just be covering,
- 2:10SPEAKER_00: you know,
- 2:10the now canceled car project or just the cost of maintaining
- 2:15their huge software
- 2:16SPEAKER_00: ecosystem?
- 2:17SPEAKER_00: Why does it have to be health AI?
- 2:18SPEAKER_01: That's a fair challenge.
- 2:20And it's where we have to connect the R&D figures to the risk
- 2:23factors they
- 2:24SPEAKER_01: themselves list in the filings.
- 2:26SPEAKER_01: When R&D grows this aggressively,
- 2:28SPEAKER_01: it signals fundamental long-term research in really high-complexity,
- 2:32SPEAKER_01: high-risk fields.
- 2:34They talk about developing products that need custom components
- 2:37available from only
- 2:38SPEAKER_01: one source and rely on new technologies.
- 2:42SPEAKER_00: So they're building everything from the ground up,
- 2:44SPEAKER_00: the sensors,
- 2:45SPEAKER_00: the silicon,
- 2:45SPEAKER_00: the whole supply chain.
- 2:47SPEAKER_01: Exactly.
- 2:47SPEAKER_01: This isn't money from minor iOS updates.
- 2:50SPEAKER_01: This is the engine funding,
- 2:51SPEAKER_01: advanced sensor technology,
- 2:54SPEAKER_01: proprietary algorithms for secure on device AI,
- 2:57SPEAKER_01: what they call private compute cloud.
- 2:59SPEAKER_01: And all the complex work for our medical grade future.
- 3:02SPEAKER_00: Like the non-invasive blood glucose project.
- 3:04SPEAKER_00: That's the kind of thing you're talking about.
- 3:05SPEAKER_01: That's the perfect example.
- 3:06SPEAKER_01: Project E5.
- 3:08SPEAKER_01: That requires billions and decades of deep fundamental research.
- 3:12SPEAKER_01: You don't get there by accident.
- 3:14SPEAKER_00: I see.
- 3:14SPEAKER_00: So this investment, it's foundational.
- 3:17They're laying the groundwork for features that will eventually
- 3:20leverage their
- 3:21SPEAKER_00: massive user base for,
- 3:23SPEAKER_00: what,
- 3:23SPEAKER_00: near zero marginal distribution costs.
- 3:25SPEAKER_01: You've hit it.
- 3:26SPEAKER_01: Exactly.
- 3:27And that leads us right to the core economic weapon of this
- 3:30whole strategy.
- 3:32SPEAKER_01: The services gross margin.
- 3:34SPEAKER_00: Ah, yes.
- 3:34SPEAKER_01: The entire plan, this whole move into high value health monitoring.
- 3:39It only works if you have an incredibly profitable delivery
- 3:42mechanism to pay for all that R&D.
- 3:45SPEAKER_00: So this is how they fund the long game.
- 3:46SPEAKER_01: OK.
- 3:47SPEAKER_00: OK.
- 3:47SPEAKER_00: So for context, what is a typical hardware company's margin look like?
- 3:50SPEAKER_01: Hardware is tough.
- 3:51SPEAKER_01: Margins can often be below 30%.
- 3:54SPEAKER_01: Apple's own products gross margin sits around 35, 36%.
- 3:57SPEAKER_01: It's solid, but it's not where the magic is.
- 4:00SPEAKER_00: The magic is in services.
- 4:02SPEAKER_01: The magic is in services.
- 4:03SPEAKER_01: The financials show this completely different dimension.
- 4:05SPEAKER_01: In 2021, the margin was 69.7%.
- 4:06SPEAKER_01: Almost 70.
- 4:06SPEAKER_01: Then 71.7% in 2022.
- 4:06SPEAKER_01: It peaked at a stunning 74.3% in 2024.
- 4:07SPEAKER_01: 74%.
- 4:07SPEAKER_01: I mean, that margin differential is the entire game.
- 4:20SPEAKER_01: So let's connect this to a real world example.
- 4:23The FDA clearance for AirPods Pro to function as a hearing
- 4:26assistance device.
- 4:28SPEAKER_00: Absolutely.
- 4:29SPEAKER_00: Think about that.
- 4:30Apple spends billions over years developing the audio
- 4:33processing to meet FDA standards.
- 4:36But when they release that medical grade feature to millions of
- 4:39people who already
- 4:40SPEAKER_00: own the hardware.
- 4:41SPEAKER_01: It's just a software update.
- 4:42It's a free software update delivered through that 70 plus
- 4:45percent margin services ecosystem.
- 4:47The marginal cost of deploying that life improving R&D heavy
- 4:52feature,
- 4:54it just approaches zero.
- 4:55SPEAKER_00: It's the ultimate business model.
- 4:56It creates a strategic advantage that traditional medical
- 5:00device companies just
- 5:01SPEAKER_00: cannot compete with.
- 5:02SPEAKER_00: They can't.
- 5:03They're bypassing the whole expensive structure of traditional
- 5:05medical device
- 5:06SPEAKER_01: manufacturing and sales.
- 5:08SPEAKER_01: But to make that leap,
- 5:09SPEAKER_01: you know,
- 5:09SPEAKER_01: from an optional gadget to a life necessity,
- 5:11SPEAKER_01: that's not just about margins.
- 5:13SPEAKER_01: You have to run straight into a wall of regulatory bodies.
- 5:16SPEAKER_01: And that's the next critical piece.
- 5:18SPEAKER_01: The shift to medical necessity is loaded with regulatory risk.
- 5:21SPEAKER_01: The filings are full of it.
- 5:23They talk about constant exposure to government investigations,
- 5:26legal actions,
- 5:26and penalties.
- 5:28But most of what we hear about are antitrust things,
- 5:30like the DMA in Europe.
- 5:32SPEAKER_00: That's about the App Store, not health care.
- 5:34SPEAKER_01: But it builds the same muscle.
- 5:37SPEAKER_01: Navigating the EU's Digital Markets Act,
- 5:39SPEAKER_01: or the FDA,
- 5:40SPEAKER_01: requires the exact same legal infrastructure,
- 5:43SPEAKER_01: the same internal compliance rigor.
- 5:45The fact that they detail these legal risks so thoroughly tells
- 5:49you that high
- 5:49SPEAKER_01: stakes,
- 5:50SPEAKER_01: regulated ventures are central to their strategy.
- 5:53SPEAKER_00: So they're building a regulatory moat.
- 5:55They're taking the heat in the consumer space as practice
- 5:59almost for the medical space.
- 6:00SPEAKER_01: It's regulatory endurance training.
- 6:02SPEAKER_01: It means even if some startup invents a better sensor tomorrow,
- 6:06they still face a decade-long process of building the trust and
- 6:09the compliance
- 6:10SPEAKER_01: infrastructure to compete at Apple's scale.
- 6:12That brings up a really important question about the business
- 6:15model itself.
- 6:16SPEAKER_00: Let's compare Apple's approach,
- 6:18SPEAKER_00: this personal general practitioner on your wrist,
- 6:21SPEAKER_00: with,
- 6:21SPEAKER_00: say,
- 6:22SPEAKER_00: Google's cloud hospital model,
- 6:24SPEAKER_00: which is all about massive data sets.
- 6:26SPEAKER_01: Right.
- 6:27SPEAKER_01: And this is where you see the quality of the business model,
- 6:30SPEAKER_01: and it all comes down to switching costs.
- 6:32SPEAKER_00: which they don't explicitly say in the 10K.
- 6:34SPEAKER_01: They don't use the word switching costs, but they describe it perfectly.
- 6:37They talk about the strength of the integrated ecosystem,
- 6:40iPhone,
- 6:41watch,
- 6:42Mac,
- 6:43iOS,
- 6:44iCloud.
- 6:45SPEAKER_01: The whole revenue model depends on that tight integration.
- 6:48SPEAKER_00: And that integration keeps customers from leaving.
- 6:51But why is health data so much stickier than,
- 6:54say,
- 6:54my photos or my financial data?
- 6:56SPEAKER_01: Because it's life critical and it's continuous.
- 6:59SPEAKER_01: When you have years of biometric data,
- 7:01SPEAKER_01: your EKG readings,
- 7:03SPEAKER_01: sleep patterns,
- 7:04maybe one day your blood glucose level is stored in that secure
- 7:07proprietary
- 7:08SPEAKER_01: ecosystem.
- 7:08SPEAKER_00: The idea of moving it somewhere else becomes.
- 7:11SPEAKER_01: It becomes almost unthinkable.
- 7:12SPEAKER_01: It's not just moving files.
- 7:13SPEAKER_01: You're moving your digital health history.
- 7:15SPEAKER_01: It's incredibly difficult.
- 7:16SPEAKER_00: And they use their privacy focus to reinforce that lock-in.
- 7:20SPEAKER_00: They're constantly talking about the risks of data loss,
- 7:24SPEAKER_00: but they frame it as their core responsibility.
- 7:26SPEAKER_01: Yes.
- 7:27SPEAKER_01: For a cloud hospital model, the huge data set is the asset.
- 7:31SPEAKER_01: For Apple, the security and privacy of your individual data is the asset.
- 7:35They're moving processing on device away from the cloud to
- 7:39reinforce that trust.
- 7:40So that secured health data becomes the foundation for a
- 7:43business model that is just...
- 7:45SPEAKER_00: Virtually unassailable.
- 7:46SPEAKER_01: It's superior business quality, plain and simple.
- 7:49SPEAKER_00: So if we put this all together,
- 7:50SPEAKER_00: the massive R&D,
- 7:51SPEAKER_00: the 70 plus percent services margin,
- 7:53SPEAKER_00: the regulatory mode and the health data lock in,
- 7:56SPEAKER_00: this whole narrative of Apple lagging in AI just sort of.
- 8:00SPEAKER_00: It collapses.
- 8:01SPEAKER_01: It completely collapses.
- 8:02SPEAKER_01: They were never in the flashy chatbot race.
- 8:04SPEAKER_01: The dimensional attack isn't about one product.
- 8:07SPEAKER_01: It's about the structural superiority of the business model itself.
- 8:11So for you listening,
- 8:12this means you shouldn't confuse silence with inaction.
- 8:15What the financial filings really show is a company sacrificing
- 8:18those short-term AI
- 8:19SPEAKER_00: hype gains for something much more permanent.
- 8:22The long-term irreversible lock-in that comes from being
- 8:26essential health infrastructure.
- 8:28SPEAKER_00: Their whole competitive edge is shifting.
- 8:30SPEAKER_00: It's not about who has the shiniest gadget anymore.
- 8:32It's about who has the most essential,
- 8:35life-critical relationship with you,
- 8:37the customer.
- 8:38SPEAKER_01: And that stability,
- 8:39SPEAKER_01: that essential relationship,
- 8:40SPEAKER_01: that is the definition of a high-quality,
- 8:43SPEAKER_01: defensible business.
- 8:44SPEAKER_00: Which leaves us with a final provocative thought for you to consider.
- 8:47SPEAKER_00: When your primary health data is being continuously managed,
- 8:50SPEAKER_00: analyzed,
- 8:51SPEAKER_00: and protected by a device you already own,
- 8:53SPEAKER_00: Does that tech company become more critical to your life than your bank?
- 8:57SPEAKER_00: Or maybe even your primary care physician?